CERO THERAPEUTICS HOLDINGS INC
CERO Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-30
2025-06-02
KUCHARCHUK ANDREW ALBERT
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
153K
$0.00
1
$88.8M
2025-05-30
2025-06-02
EHRLICH CHRISTOPHER
Chairman and CEO
A - Grant
Stock Option (Right to Buy)
61,843
$0.00
1
$88.8M
2025-05-30
2025-06-02
PIERCE KRISTEN
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
155K
$0.00
1
$88.8M
2025-03-04
2025-03-06
EHRLICH CHRISTOPHER
Chairman and CEO
A - Grant
Stock Option (Right to Buy)
119K
$0.00
1
$88.8M
2025-02-24
2025-02-26
EHRLICH CHRISTOPHER
Chairman and CEO
A - Grant
Stock Option (Right to Buy)
1.27M
$0.00
1
$88.8M
2025-02-07
2025-02-07
ATWOOD BRIAN
A - Grant
Warrant to Purchase Shares of Common Stock
510K
$2.00
1.02M
2
$88.8M
2024-12-13
2024-12-13
YK BIOVENTURES OPPORTUNITIES GP I, LLC
S - Sale
Common Stock
-3.00M
$0.00
1
$88.8M
2024-12-12
2024-12-13
YK BIOVENTURES OPPORTUNITIES GP I, LLC
S - Sale
Common Stock
-1.61M
$0.00
1
$88.8M
2024-12-11
2024-12-13
YK BIOVENTURES OPPORTUNITIES GP I, LLC
S - Sale
Common Stock
-1.34M
$0.00
1
$88.8M
2024-12-10
2024-12-10
YK BIOVENTURES OPPORTUNITIES GP I, LLC
S - Sale
Common Stock
-1.57M
$0.00
1
$88.8M
2024-12-06
2024-12-10
YK BIOVENTURES OPPORTUNITIES GP I, LLC
S - Sale
Common Stock
-1.24M
$0.00
1
$88.8M
2024-12-02
2024-12-04
EHRLICH CHRISTOPHER
Chairman and CEO
A - Grant
Stock Option (Right to Buy)
1.27M
$0.00
1
$88.8M
2024-09-25
2024-11-20
SLOAN STUART
S - Sale
Common Stock, $0.0001 par value per share
-532K
$0.00
1
$88.8M
2024-10-10
2024-11-14
YK BIOVENTURES OPPORTUNITIES GP I, LLC
S - Sale
Common Stock
-3.25M
$0.00
1
$88.8M
2024-10-01
2024-10-02
PIERCE KRISTEN
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$88.8M
2024-10-01
2024-10-02
KUCHARCHUK ANDREW ALBERT
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
500K
$0.00
1
$88.8M
2024-09-30
2024-10-02
EHRLICH CHRISTOPHER
Interim Chairman and CEO
D - Sale to Issuer
Stock Option (Right to Buy)
-572K
$0.00
1
$88.8M
2024-09-25
2024-10-02
LAPORTE KATHLEEN
M - Exercise
Series A Convertible Preferred Stock
-50
$1,000.00
-50,000
1
$88.8M
2024-09-25
2024-10-02
ATWOOD BRIAN
M - Exercise
Series A Convertible Preferred Stock
-1,002
$1,000.00
-1.00M
1
$88.8M
2024-09-25
2024-10-02
EHRLICH CHRISTOPHER
Interim Chairman and CEO
M - Exercise
Series A Convertible Preferred Stock
-275
$1,000.00
-275K
1
$88.8M
2024-09-25
2024-10-02
EHRLICH CHRISTOPHER
Interim Chairman and CEO
M - Exercise
Common Stock
5.31M
1
$88.8M
2024-06-28
2024-07-01
CARTER CHARLES ROSS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$88.8M
2024-03-25
2024-03-27
ATWOOD BRIAN
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
1.32M
$0.00
1
$88.8M
2024-03-25
2024-03-27
CARTER CHARLES ROSS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
395K
$0.00
1
$88.8M
2024-03-25
2024-03-27
COREY DANIEL
Chief Technical Officer
A - Grant
Stock Option (Right to Buy)
857K
$0.00
1
$88.8M
2024-02-14
2024-03-11
ATWOOD BRIAN
Chief Executive Officer
A - Grant
Series A Convertible Preferred Stock
1,002
$1,000.00
1.00M
1
$88.8M
2024-02-14
2024-03-11
ATWOOD BRIAN
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
13,857
$0.00
1
$88.8M
2024-02-14
2024-02-21
ATWOOD BRIAN
Chief Executive Officer
A - Grant
Series A Convertible Preferred Stock
1,002
$1,000.00
1.00M
1
$88.8M
2024-02-14
2024-02-21
LAPORTE KATHLEEN
A - Grant
Series A Convertible Preferred Stock
50
$1,000.00
50,000
1
$88.8M
2024-02-14
2024-02-16
PHOENIX BIOTECH SPONSOR, LLC
J - Other
Series A Convertible Preferred Stock
-1,555
$1,000.00
-1.55M
1
$88.8M
2024-02-14
2024-02-16
ATWOOD BRIAN
Chief Executive Officer
A - Grant
Series A Convertible Preferred Stock
1,002
$1,000.00
1.00M
1
$88.8M
2024-02-14
2024-02-16
EHRLICH CHRISTOPHER
A - Grant
Series A Convertible Preferred Stock
100
$1,000.00
100K
1
$88.8M
2024-02-14
2024-02-16
FISHER DOUGLAS CARL
President
A - Grant
Series A Convertible Preferred Stock
50
$1,000.00
50,000
1
$88.8M
2024-02-14
2024-02-16
LAPORTE KATHLEEN
A - Grant
Series A Convertible Preferred Stock
50
$1,000.00
50,000
1
$88.8M
2024-02-14
2024-02-16
EHRLICH CHRISTOPHER
J - Other
Series A Convertible Preferred Stock
175
$1,000.00
175K
1
$88.8M
2024-02-14
2024-02-16
EHRLICH CHRISTOPHER
J - Other
Series A Convertible Preferred Stock
-1,555
$1,000.00
-1.55M
1
$88.8M
2024-02-14
2024-02-16
GEFFKEN DANIEL
Chief Financial Officer
J - Other
Class A Common Stock
10,002
1
$88.8M
2024-02-14
2024-02-16
EHRLICH CHRISTOPHER
M - Exercise
Series A Convertible Preferred Stock
1,555
$1,000.00
1.55M
1
$88.8M
2024-02-14
2024-02-16
PHOENIX BIOTECH SPONSOR, LLC
M - Exercise
Series A Convertible Preferred Stock
1,555
$1,000.00
1.55M
1
$88.8M